Forgot your password?
Vtama cream demonstrated statistically significant efficacy across a range of skin tones
The medicine was evaluated in 50 patients with moderate-to-severe cases of the condition and darker skin tones
The drug is already approved in the EU to treat plaque psoriasis, psoriatic arthritis and axial spondyloarthritis
The Vitiligo Society has called for greater awareness surrounding the condition
JNJ-2113 is the first targeted oral peptide designed to block the IL-23 receptor
Almirall will gain global rights to develop and commercialise the asset in rare dermatological and other diseases associated with nonsense mutations
The STREAM-AD study showed sustained improvements in the signs and symptoms of the condition for 28 weeks
The treatment is already approved for use in atopic dermatitis non-segmental vitiligo
The decision is expected to benefit up to 14,000 patients living with the autoimmune disease
The candidate has been developed up to mid-stage in non-dermatological indications